Skip to content
10-Q

Quarterly Report

TANDEM DIABETES CARE INC TNDM

0001438133-25-000187

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 4, 2025 67.8M sh
Shares Diluted Q3 2025 · Sep 30, 2025 67.65M sh
Shares Diluted Q3 2025 · Sep 30, 2025 67.04M sh
Shares Diluted Q3 2025 · Sep 30, 2024 65.54M sh
Shares Diluted Q3 2025 · Sep 30, 2024 65.29M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $0
Stock Repurchased Q3 2025 · Sep 30, 2024 $30M
Capex Q3 2025 · Sep 30, 2025 $13.26M
Capex Q3 2025 · Sep 30, 2024 $16.16M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$19.51M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $13.51M
Long Term Debt Q3 2025 · Sep 30, 2025 $309.59M
Long Term Debt Q3 2025 · Dec 31, 2024 $308.27M
Short Term Investments Q3 2025 · Sep 30, 2025 $227.16M
Short Term Investments Q3 2025 · Dec 31, 2024 $369.1M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $91.95M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $69.23M
Stockholders Equity Q3 2025 · Sep 30, 2025 $132.97M
Stockholders Equity Q3 2025 · Jun 30, 2025 $133.28M
Stockholders Equity Q3 2025 · Dec 31, 2024 $263.1M
Stockholders Equity Q3 2025 · Sep 30, 2024 $237.71M
Stockholders Equity Q3 2025 · Jun 30, 2024 $233.88M
Stockholders Equity Q3 2025 · Dec 31, 2023 $313.63M
Current Liabilities Q3 2025 · Sep 30, 2025 $252.54M
Current Liabilities Q3 2025 · Dec 31, 2024 $247.05M
Total Liabilities Q3 2025 · Sep 30, 2025 $741.69M
Total Liabilities Q3 2025 · Dec 31, 2024 $704.56M
Current Assets Q3 2025 · Sep 30, 2025 $616.94M
Current Assets Q3 2025 · Dec 31, 2024 $724.49M
Total Assets Q3 2025 · Sep 30, 2025 $874.65M
Total Assets Q3 2025 · Dec 31, 2024 $967.66M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.31
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.04
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.35
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.48
Eps Basic Q3 2025 · Sep 30, 2025 −$0.31
Eps Basic Q3 2025 · Sep 30, 2025 −$3.04
Eps Basic Q3 2025 · Sep 30, 2024 −$0.35
Eps Basic Q3 2025 · Sep 30, 2024 −$1.48
Sga Expense Q3 2025 · Sep 30, 2025 $108.44M
Sga Expense Q3 2025 · Sep 30, 2025 $331.89M
Sga Expense Q3 2025 · Sep 30, 2024 $99.64M
Sga Expense Q3 2025 · Sep 30, 2024 $283.99M
Net Income Q3 2025 · Sep 30, 2025 −$21.17M
Net Income Q3 2025 · Sep 30, 2025 −$204.12M
Net Income Q3 2025 · Sep 30, 2024 −$23.25M
Net Income Q3 2025 · Sep 30, 2024 −$96.78M
Operating Income Q3 2025 · Sep 30, 2025 −$22.86M
Operating Income Q3 2025 · Sep 30, 2025 −$195.55M
Operating Income Q3 2025 · Sep 30, 2024 −$26.09M
Operating Income Q3 2025 · Sep 30, 2024 −$98.55M
Gross Profit Q3 2025 · Sep 30, 2025 $134.29M
Gross Profit Q3 2025 · Sep 30, 2025 $378.55M
Gross Profit Q3 2025 · Sep 30, 2024 $124.65M
Gross Profit Q3 2025 · Sep 30, 2024 $332.12M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $114.96M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $345.8M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $119.32M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $325.44M
Revenue Q3 2025 · Sep 30, 2025 $249.25M
Revenue Q3 2025 · Sep 30, 2025 $724.35M
Revenue Q3 2025 · Sep 30, 2024 $243.97M
Revenue Q3 2025 · Sep 30, 2024 $657.56M